LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced financial results for the three- and nine-month periods ended September 30, 2010. Third quarter results are not typical of past or future quarters due to the accounting for the sale of the Company’s progesterone related assets to Watson Pharmaceuticals, the concurrent elimination of all Company debt effective July 2, 2010, and certain one-time expenses. Key financial results for the quarter and subsequent events include:
